Cholesterol, LDL: Clinical Trials

4 trials of Cholesterol, LDL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Completed 1

Follow Cholesterol, LDL: new trials by email Literature Review of Cholesterol, LDL trials Research Report on Cholesterol, LDL

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metabolic Profile as a Predictor of No-reflow in Diabetic Patients
1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S - Acute Myocardial Infarction (AMI)
UnknownEl Zahraa Gamal1202021-04-012021-04-08
Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers
Point-of-care bio-markers (cTnI, hsCRP, D-Dimer) and biological parameters (CBC, glucose, cholesterol, LDL cholesterol, triglycerides, fibrinogen) - Cerebral Hemorrhage
CompletedIuliu Hatieganu University of Medicine and Pharmacy392016-12-122019-07-23
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
Evolocumab, Low-density Lipoprotein Cholesterol (LDL-C) Apheresis - Hypercholesterolemia
Phase 3CompletedAmgen392015-12-212022-11-30
The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients
LDL-cholesterol - Hypercholesterolemia
Not applicableCompletedClinical Research Center for End Stage Renal Disease, Korea432009-10-012017-03-17

Conditions studied

Hypercholesterolemia (2)  ·  Cerebral Hemorrhage (1)  ·  Emergencies (1)  ·  Hyperlipoproteinemia Type II (1)

Sponsors

Amgen (1)  ·  Clinical Research Center for End Stage Renal Disease, Korea (1)  ·  El Zahraa Gamal (1)  ·  Iuliu Hatieganu University of Medicine and Pharmacy (1)

Countries

Australia (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Romania (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Eugenia M Muresan, MD, PhD stud (1)  ·  Shin-Wook Kang, M.D., PhD. (1)

NIH funding

2015 (1)